ADVL 1615: A phase 1 Study of Pevonedistat (MLN4924), A Cullin Ligase Inhibitor, In Combination with Temozolomide and Irinotecan in Pediatric Patients with Recurrent or Refactory Solid Tumors

Grant

Date/time Interval

  • June 27, 2018 - June 26, 2022
  • Total Award Amount

  • 11050.00
  • Direct Costs

  • 8500.00
  • Sponsor Award Id

  • Contributor

  • Alva, Elizabeth   Investigator  
  • Aye, Jamie   Investigator  
  • Friedman, Gregory   Principal Investigator  
  • Galtarossa Xavier, Ana   Investigator  
  • Kutny, Matthew   Investigator  
  • Liang, Wayne   Investigator  
  • Whelan, Kimberly   Investigator